Stoke Therapeutics Inc
NASDAQ:STOK

Watchlist Manager
Stoke Therapeutics Inc Logo
Stoke Therapeutics Inc
NASDAQ:STOK
Watchlist
Price: 11.68 USD 3.36% Market Closed
Market Cap: 618.7m USD
Have any thoughts about
Stoke Therapeutics Inc?
Write Note

Wall Street
Price Targets

STOK Price Targets Summary
Stoke Therapeutics Inc

Wall Street analysts forecast STOK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STOK is 22.95 USD with a low forecast of 15.15 USD and a high forecast of 36.75 USD.

Lowest
Price Target
15.15 USD
30% Upside
Average
Price Target
22.95 USD
96% Upside
Highest
Price Target
36.75 USD
215% Upside

STOK Last Price Targets
Stoke Therapeutics Inc

The latest public price target was made on Oct 11, 2024 by Marc Goodman from Leerink Partners , who expects STOK stock to rise by 54% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Marc Goodman
Leerink Partners
18 USD
Upside 54%
2 months ago
Oct 11, 2024
Stoke Therapeutics assumed with an Outperform at Leerink
TheFly
Debjit Chattopadhyay
H.C. Wainwright
35 USD
Upside 200%
3 months ago
Sep 11, 2024
H.C. Wainwright Reiterates Buy Rating on Stoke Therapeutics (STOK)
StreetInsider
Sumant Kulkami
Canaccord Genuity
20 USD
Upside 71%
7 months ago
May 7, 2024
Stoke Therapeutics (STOK) PT Lowered to $20 at Canaccord Genuity
StreetInsider
Joseph Stringer
Needham
22 USD
Upside 88%
8 months ago
Mar 26, 2024
Stoke Therapeutics (STOK) PT Raised to $22 at Needham, latest STK-001 'data put STOK in a strong position heading into regulatory discussions'
StreetInsider
Sumant Kulkami
Canaccord Genuity
21 USD
Upside 80%
8 months ago
Mar 26, 2024
Stoke Therapeutics (STOK) PT Raised to $21 at Canaccord Genuity
StreetInsider
Marc Goodman
Leerink Partners
Price Target 18 USD
Upside/Downside 54%
View Source
Debjit Chattopadhyay
H.C. Wainwright
Price Target 35 USD
Upside/Downside 200%
View Source
Sumant Kulkami
Canaccord Genuity
Price Target 20 USD
Upside/Downside 71%
View Source
Joseph Stringer
Needham
Price Target 22 USD
Upside/Downside 88%
View Source
Sumant Kulkami
Canaccord Genuity
Price Target 21 USD
Upside/Downside 80%
View Source
Stoke Therapeutics Inc Competitors:
Price Targets
2162
KeyMed Biosciences Inc
87% Upside
CCCC
C4 Therapeutics Inc
317% Upside
SPRO
Spero Therapeutics Inc
434% Upside
XNCR
Xencor Inc
37% Upside
NANO
Nanobiotix SA
332% Upside
377740
BioNote Inc
20% Upside
214450
PharmaResearch Co Ltd
12% Upside
002007
Hualan Biological Engineering Inc
20% Upside

Revenue
Forecast

Revenue Estimate
Stoke Therapeutics Inc

The compound annual growth rate of Stoke Therapeutics Inc's revenue for the next 4 years is 62%.

N/A
Past Growth
62%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Stoke Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Stoke Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is STOK's stock price target?
Price Target
22.95 USD

According to Wall Street analysts, the average 1-year price target for STOK is 22.95 USD with a low forecast of 15.15 USD and a high forecast of 36.75 USD.

What is Stoke Therapeutics Inc's Revenue forecast?
Projected CAGR
62%

The compound annual growth rate of Stoke Therapeutics Inc's revenue for the next 4 years is 62%.

Back to Top